Jun Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jun Wu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Chaoxue Zhang
First Affiliated Hospital of Anhui Medical University
1 shared publicationFan Jiang
Second Affiliated Hospital of Anhui Medical University
1 shared publication- Fan Li
Department of Ultrasound Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
1 shared publication - Fang Ma
Department of Ultrasound Medicine, The Second People’s Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei 230011, China
1 shared publication - Ji’Ao You
Department of Ultrasound Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
1 shared publication - Nuo Xu
Department of Ultrasound Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
1 shared publication
Latest Publications
- Open Access
- 8 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (8) , 1119
Prospective Pilot Study of Ultrasound Resolution Microscopy Imaging (URM) for Differentiating Benign and Malignant Breast Lesions: A Quantitative Microvascular Parameter Analysis
Objective: Ultrasound Resolution Microscopy (URM) is an emerging technique that provides superior delineation of tumor microvasculature. This prospective study aimed to evaluate the diagnostic value of URM in differentiating benign from malignant breast lesions. Methods: From September 2024 to October 2025, 55 patients with 57 breast masses underwent conventional ultrasound and contrast-enhanced URM. Microvascular parameters were quantitatively analyzed and cross-referenced with histopathology. To mitigate overfitting, LASSO regression was employed to screen 14 URM indices. A combined predictive model integrating core URM features with BI-RADS categorization (dichotomized at 4A) was developed and evaluated using ROC and decision curve analysis (DCA). Results: Thirty-four malignant and 23 benign masses were confirmed. Malignant lesions exhibited comprehensively elevated microvascular abundance and architectural chaos. LASSO regression distilled these features down to two core independent predictors: Vessel Count and Max Curvature. The BI-RADS-alone model yielded 100% sensitivity but extremely low specificity (30.43%). Crucially, the Combined model significantly outperformed the single-modality approaches, achieving an excellent AUC of 0.896 (vs. 0.652 for BI-RADS alone, p < 0.001). By integrating URM parameters, the Combined model maintained adequate sensitivity (73.53%) while drastically boosting specificity to 91.30%. DCA confirmed superior net clinical benefit for the combined strategy. Conclusions: Quantitative URM imaging effectively characterizes the distinct microvascular features of breast cancers. Integrating URM functional parameters with conventional BI-RADS categorization significantly improves diagnostic specificity. Consequently, this combined approach provides a reliable non-invasive strategy to optimize risk stratification, effectively minimizing false-positive diagnoses and averting unnecessary invasive biopsies in routine clinical practice.
- 8 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (8) , 1119
Open AccessProspective Pilot Study of Ultrasound Resolution Microscopy Imaging (URM) for Differentiating Benign and Malignant Breast Lesions: A Quantitative Microvascular Parameter Analysis
Objective: Ultrasound Resolution Microscopy (URM) is an emerging technique that provides superior delineation of tumor microvasculature. This prospective study aimed to evaluate the diagnostic value of URM in differentiating benign from malignant breast lesions. Methods: From September 2024 to October 2025, 55 patients with 57 breast masses underwent conventional ultrasound and contrast-enhanced URM. Microvascular parameters were quantitatively analyzed and cross-referenced with histopathology. To mitigate overfitting, LASSO regression was employed to screen 14 URM indices. A combined predictive model integrating core URM features with BI-RADS categorization (dichotomized at 4A) was developed and evaluated using ROC and decision curve analysis (DCA). Results: Thirty-four malignant and 23 benign masses were confirmed. Malignant lesions exhibited comprehensively elevated microvascular abundance and architectural chaos. LASSO regression distilled these features down to two core independent predictors: Vessel Count and Max Curvature. The BI-RADS-alone model yielded 100% sensitivity but extremely low specificity (30.43%). Crucially, the Combined model significantly outperformed the single-modality approaches, achieving an excellent AUC of 0.896 (vs. 0.652 for BI-RADS alone, p < 0.001). By integrating URM parameters, the Combined model maintained adequate sensitivity (73.53%) while drastically boosting specificity to 91.30%. DCA confirmed superior net clinical benefit for the combined strategy. Conclusions: Quantitative URM imaging effectively characterizes the distinct microvascular features of breast cancers. Integrating URM functional parameters with conventional BI-RADS categorization significantly improves diagnostic specificity. Consequently, this combined approach provides a reliable non-invasive strategy to optimize risk stratification, effectively minimizing false-positive diagnoses and averting unnecessary invasive biopsies in routine clinical practice.
- Open Access
- 11 April 2023
- Published by Springer Nature in Research Square
Comparison of microwave alone and combined with ethanol ablation for different types of benign cystic solid thyroid nodules
Objective To evaluate the efficacy and safety of microwave ablation (MWA) plus ethanol ablation (EA) for different types of benign cystic solid thyroid nodules.Methods A total of 81 patients with 81 benign cystic solid thyroid nodules were enrolled into the study; 39 were divided to the MWA group and 42 to the combined group (MWA combined with EA). Nodule inactivation rate, volume reduction rate (VRR) and surgical complications of all patients were analyzed before and after treatment.Results The mean inactivation rate were 86.49 ± 6.68% and 90.09 ± 5.79% in the microwave and combined groups respectively, and the inactivation rate of nodule decreased as the nodule volume increased. For nodules ≥ 15 ml in volume, the mean inactivation rate of the combined group was higher than that of the microwave group (all P < 0.05). The mean VRR at 12 months postoperatively was 89.58 ± 4.32% in the microwave group and 92.92 ± 3.49% in the combined group, showing statistical significantly different between both arms (P = 0.001). The combined group decreased in volume more significantly than the microwave group for nodules with 20%-50% or 50%-80% cystic proportions or > 15 ml in volume (all P < 0.05). The complication rate was 23.08% and 2.38% respectively.Conclusion MWA combined with EA is more effective than MWA for treating cystic solid thyroid nodules. MWA combined with EA may be the first approach for nodules with > 20% cystic proportions or volume > 15 ml.
- 11 April 2023
- Published by Springer Nature in Research Square
Open AccessComparison of microwave alone and combined with ethanol ablation for different types of benign cystic solid thyroid nodules
Objective To evaluate the efficacy and safety of microwave ablation (MWA) plus ethanol ablation (EA) for different types of benign cystic solid thyroid nodules.Methods A total of 81 patients with 81 benign cystic solid thyroid nodules were enrolled into the study; 39 were divided to the MWA group and 42 to the combined group (MWA combined with EA). Nodule inactivation rate, volume reduction rate (VRR) and surgical complications of all patients were analyzed before and after treatment.Results The mean inactivation rate were 86.49 ± 6.68% and 90.09 ± 5.79% in the microwave and combined groups respectively, and the inactivation rate of nodule decreased as the nodule volume increased. For nodules ≥ 15 ml in volume, the mean inactivation rate of the combined group was higher than that of the microwave group (all P < 0.05). The mean VRR at 12 months postoperatively was 89.58 ± 4.32% in the microwave group and 92.92 ± 3.49% in the combined group, showing statistical significantly different between both arms (P = 0.001). The combined group decreased in volume more significantly than the microwave group for nodules with 20%-50% or 50%-80% cystic proportions or > 15 ml in volume (all P < 0.05). The complication rate was 23.08% and 2.38% respectively.Conclusion MWA combined with EA is more effective than MWA for treating cystic solid thyroid nodules. MWA combined with EA may be the first approach for nodules with > 20% cystic proportions or volume > 15 ml.